Jump to content

Dana–Farber Cancer Institute: Difference between revisions

m
Text replacement - "Boston" to "Boston"
No edit summary
m (Text replacement - "Boston" to "Boston")
 
Line 14: Line 14:
{{Short description|Cancer treatment and research institution in Boston, US}}
{{Short description|Cancer treatment and research institution in Boston, US}}


'''Dana–Farber Cancer Institute''' ('''DFCI''') is a comprehensive [[cancer]] treatment and research center in [[Boston]], [[Massachusetts]]. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's [[Comprehensive Cancer Center]] designated by the [[National Cancer Institute]], and one of the 15 clinical affiliates and research institutes of [[Harvard Medical School]].
'''Dana–Farber Cancer Institute''' ('''DFCI''') is a comprehensive [[cancer]] treatment and research center in Boston, [[Massachusetts]]. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's [[Comprehensive Cancer Center]] designated by the [[National Cancer Institute]], and one of the 15 clinical affiliates and research institutes of [[Harvard Medical School]].


As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world.<ref>{{Cite web |last=Newsweek |date=2022-09-14 |title=World's Best Specialized Hospitals 2023 |url=https://www.newsweek.com/rankings/worlds-best-specialized-hospitals-2023 |access-date=2023-01-02 |website=Newsweek |language=en}}</ref> Two [[Nobel Prize in Physiology or Medicine|Nobel laureates in Physiology or Medicine]] are among its past and present faculty.
As of 2023, Dana-Farber is ranked the #4 cancer hospital in the world.<ref>{{Cite web |last=Newsweek |date=2022-09-14 |title=World's Best Specialized Hospitals 2023 |url=https://www.newsweek.com/rankings/worlds-best-specialized-hospitals-2023 |access-date=2023-01-02 |website=Newsweek |language=en}}</ref> Two [[Nobel Prize in Physiology or Medicine|Nobel laureates in Physiology or Medicine]] are among its past and present faculty.